3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Plasmacytoma
1
Interventions
Dexamethasone
8
Lenalidomide
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
daratumumab
3
auricularum
3
Calcium Dobesilate
3
Bortezomib
3
pomalidomide
2
ixazomib
2
filanesib
2
Steroids
2
Radiotherapy
2
Injections, Subcutaneous
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
silmitasertib
1
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
milatuzumab
1
cc-486
1
carfilzomib
1
Thalidomide
1
Specimen Handling
1
Sodium Selenite
1
Radiation
1
Proteasome Inhibitors
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Plasmacytoma
×
Drug Combinations
×
Plasma cell
×
Clear all
NCT04065308
2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2
Unknown
33 enrolled